My name is Eric Strati, CEO of Gift of Life Biologics. Gift of Life Biologics has exclusive access to Gift of Life Marrow Registry to develop and provide cellular material (starting material/leukopaks) for biopharmaceutical and research organizations.
Gift of Life Biologics is the only fully integrated provider of cellular material, featuring an apheresis center and a cell and gene lab for cell processing, isolation and cryopreservation – all supported by a world-renowned registry of approximately 500,000 highly characterized healthy donors. The facility spans 50,000 square feet and offers products for both research use only (RUO) and GTP/GMP purposes. Our integrated approach enables us to consistently provide the highest quality material and meet the custom and complex requirements of the life science field in the most cost-effective manner.
I am most proud of how Gift of Life Biologics, with the full support of the Gift of Life Marrow Registry, has quickly evolved to offer a broad range of products. These include both RUO and GTP/GMP products, dual-mobilized leukopaks, various cell isolation offerings and the launch of our biobank. This further enables the industry to advance potentially lifesaving and transforming cellular therapies. Supporting our customers and the broader life science field by advancing cell and gene therapies is core to our facility's mission of advancing cures for cancer and other illnesses.
Eric Strati, CEO, Gift of Life BiologicsAABB accreditation has been incredibly beneficial for Gift of Life Biologics, both in differentiating our organization within the field as a trusted cellular material provider and by expediting required initial quality assessments of new customers, along with seamlessly responding to routine quality audits.
Given the ongoing growing demand for apheresis, Gift of Life has recently undertaken an initiative to double our apheresis capacity. We anticipate new capacity coming online during the first half of 2025.
Given the ongoing growing demand for apheresis, Gift of Life has recently undertaken an initiative to double our apheresis capacity. We anticipate new capacity coming online during the first half of 2025.
I highly encourage other facilities to engage closely with AABB and to pursue accreditation, especially for those servicing the life science field. AABB is a true partner in supporting facilities with the required procedural systems to consistently produce the highest quality cellular material from healthy donors in the safest manner.
Gift of Life Biologics is a vertically integrated provider of cellular material (starting material / leukopaks ) from healthy donors, offering access to a world-renowned international registry (~500,000 well characterized healthy donors) with on-site capabilities, including apheresis, laboratory, cell processing and isolation, and GMP ISO class 7 clean rooms. Gift of Life Biologics is uniquely positioned to support innovators of allogeneic cell and gene therapies sourcing high quality healthy donor starting material across all stages from research use to global therapeutic commercialization.
AABB Accreditation is an international mark of excellence that demonstrates your facility's commitment to quality and safety. Biotherapies facilities can become AABB-Accredited via the Standards for Cellular Therapy Services.
Learn how AABB Accreditation can bring value to your facility.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
